Compound for regulating and controlling 15-PGDH activity and preparation method therefor

By providing a new compound, using its specific structural characteristics to react with the 15-PGDH enzyme, the need to regulate 15-PGDH activity is solved, effective inhibition of 15-PGDH enzyme and upregulation of PGE2 activity is achieved, and treatment is achieved. The potential of fibrosis and inflammatory diseases.

WO2024240086A1PCT designated stage expired Publication Date: 2024-11-28CHENGDU BRILLIANT PHARMA CO LTD +1
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/093993
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-19
Filing Date
2024-05-17
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Existing 15-PGDH inhibitors and agonists have limitations in the treatment of related diseases, especially in the lack of effective small-molecule compounds in the regulation of 15-PGDH activity.

Method used

A novel compound with specific structural characteristics is provided, which can act as an inhibitor of 15-PGDH, regulate its activity by reacting with 15-PGDH enzyme, and can upregulate the activity of PGE2 in vivo. The structure of the compound includes aromatic rings, aromatic heterocycles, unsaturated lipid heterocycles, etc., and is prepared by a specific chemical reaction synthesis method.

Benefits of technology

This compound can effectively inhibit the activity of 15-PGDH enzyme, significantly increase the IC50 value, and upregulate the activity of PGE2 in cells, and has potential effects on the treatment of fibrosis, inflammatory diseases and other diseases related to 15-PGDH.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024093993_28112024_PF_FP_ABST
    Figure CN2024093993_28112024_PF_FP_ABST
Patent Text Reader

Abstract

The present application relates to a compound of formula (I) for regulating and controlling 15-PGDH activity, a stereoisomer thereof, a tautomer thereof or a mixture thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, or a prodrug thereof, a pharmaceutical composition containing same, and the use thereof for inhibiting 15-PGDH activity.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Compositions and methods of modulating short-chain dehydrogenase activity

    CN108012528A

  • Compositions and methods of modulating short-chain dehydrogenase activity

    CN110573154A

  • 15-PGDH inhibitor

    CN113226310A

  • Heterocyclic inhibitors of histamine receptors for the treatment of disease

    WO2011112731A2

  • 15-PGDH inhibitors

    WO2020160151A1